TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15039249

Group type: EXPERIMENTAL
Intervention: Pre-season dance training for 12 weeks (n = 16)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 26
Study: 11376828

Group type: COMPARATOR
Intervention: Subcutaneous patch electrode
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Subcutaneous array electrode
Number of subjects: 30
Study: 9692286

Group type: EXPERIMENTAL
Intervention: Motivational interviewing by practice nurses
Number of subjects: 0
Study: 7823270

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine mouthrinse (positive control)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Experimental CPC/essential oil mouthrinse
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer prebrushing mouthrinse
Number of subjects: 15

Group type: COMPARATOR
Intervention: Negative control rinses (two types)
Number of subjects: 15
Study: 3167526

Group type: EXPERIMENTAL
Intervention: Nefopam hydrochloride (20 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 28981312

Group type: EXPERIMENTAL
Intervention: Physical assault and sexual victimization by intimate partners
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: PTSD symptoms
Number of subjects: 179
Study: 27894271

Group type: EXPERIMENTAL
Intervention: Physical exercise program involving progressive and challenging balance training and neuromuscular and functional training of the lower limbs, conducted at home by physiotherapists, once a week for the first three months, and twice a week at home thereafter, totaling 18 sessions.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 82
Study: 25063725

Group type: EXPERIMENTAL
Intervention: iNO (10 ppm)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo gas (controls)
Number of subjects: 124
Study: 22462558

Group type: EXPERIMENTAL
Intervention: Amlodipine/losartan 5 mg/100 mg combination
Number of subjects: 142

Group type: COMPARATOR
Intervention: Losartan 100 mg
Number of subjects: 142
Study: 20569455

Group type: EXPERIMENTAL
Intervention: Dietary supplement containing polyunsaturated fatty acids and Humulus lupulus extract (active group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olive oil (placebo group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary supplement (active group)
Number of subjects: 0
Study: 18501669

Group type: EXPERIMENTAL
Intervention: Cardiac transplant patients
Number of subjects: 38

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 38
Study: 15928240

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (60% carbohydrate, 25% fat)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (30% carbohydrate, 55% fat)
Number of subjects: 13
Study: 12762083

Group type: EXPERIMENTAL
Intervention: Telephone-based smoking cessation intervention
Number of subjects: 59
Study: 10512920

Group type: EXPERIMENTAL
Intervention: EuroQol
Number of subjects: 2253

Group type: EXPERIMENTAL
Intervention: SF-36
Number of subjects: 2253
Study: 8624233

Group type: EXPERIMENTAL
Intervention: Wisdom Straight toothbrush
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wisdom Plaque Control toothbrush
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wisdom Angled toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral-B 35 toothbrush
Number of subjects: 0
Study: 1828549

Group type: EXPERIMENTAL
Intervention: Direct insertion of reusable conventional laparoscopic trocar
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Direct insertion of disposable shielded trocar
Number of subjects: 200

Group type: COMPARATOR
Intervention: Previous pneumoperitoneum by Veress needle insertion
Number of subjects: 200
Study: 6991353

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 31912674

Group type: EXPERIMENTAL
Intervention: Completion hysterectomy after CCRT
Number of subjects: 175

Group type: COMPARATOR
Intervention: Surveillance after CCRT
Number of subjects: 175
Study: 29616587

Group type: EXPERIMENTAL
Intervention: Antegrade fixation with a cannulated headless compression screw
Number of subjects: 22

Group type: COMPARATOR
Intervention: Retrograde fixation with a cannulated headless compression screw
Number of subjects: 22
Study: 28025309

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) using the Prevena NPWT device
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 64
Study: 27515752

Group type: EXPERIMENTAL
Intervention: Gentle suprapubic cutaneous stimulation using cold saline-soaked gauze in circular motions
Number of subjects: 354

Group type: COMPARATOR
Intervention: No stimulation (control)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Gentle suprapubic cutaneous stimulation using cold saline-soaked gauze
Number of subjects: 354
Study: 24928948

Group type: EXPERIMENTAL
Intervention: Dual-chamber ICDs
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single-chamber ICDs
Number of subjects: 100
Study: 22732468

Group type: EXPERIMENTAL
Intervention: Therapeutic vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ATI week 16
Number of subjects: 0
Study: 19810667

Group type: EXPERIMENTAL
Intervention: Creative reflective assignment in a community psychosocial program for 4 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional 14-week clinical experience
Number of subjects: 73
Study: 18474463

Group type: EXPERIMENTAL
Intervention: MAS065D
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 40
Study: 16192542

Group type: EXPERIMENTAL
Intervention: 20 cm distal to the greater trochanter (group proximal)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 30 cm distal to the greater trochanter (group distal)
Number of subjects: 50
Study: 12894612

Group type: EXPERIMENTAL
Intervention: Clonazepam (4 weeks treatment)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (4 weeks treatment)
Number of subjects: 27
Study: 10227808

Group type: EXPERIMENTAL
Intervention: Inhaled interleukin-5 (IL-5)
Number of subjects: 8
Study: 8916983

Group type: EXPERIMENTAL
Intervention: Add-back hormone replacement therapy (HRT) with cyclical oestradiol/norgestrol in combination with Zoladex (goserelin acetate)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combined oestrogen/progestogen given for 21 months after initial GnRH agonist treatment for 3 months
Number of subjects: 51

Group type: COMPARATOR
Intervention: Progestogen only
Number of subjects: 51
Study: 8445225

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon, 6 million units, intramuscularly, once per week for 24 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon
Number of subjects: 36
Study: 3953351

Group type: EXPERIMENTAL
Intervention: Intravenous lorcainide (LOR) 2 mg/kg then 200 mg/24hr
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lidocaine (LID) 1 mg/kg then 2 mg/min
Number of subjects: 30
Study: 30045770

Group type: EXPERIMENTAL
Intervention: Rock and Water intervention (Light condition: core team of teachers trained)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Rock and Water intervention (Standard condition: core team of teachers and whole school team trained)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Rock and Water intervention (Plus condition: core team of teachers, whole school team trained, and parents involved)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Control condition (Care As Usual)
Number of subjects: 720
Study: 27716692

Group type: EXPERIMENTAL
Intervention: Marked introducer needle
Number of subjects: 62

Group type: COMPARATOR
Intervention: Unmarked introducer needle
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 24643636

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (180 mg eicosapentaenoic acid and 120 mg docosahexaenoic acid), three times daily for 4 months
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 25119571

Group type: EXPERIMENTAL
Intervention: Uzara (80 mg/8 hours for two doses, then 40 mg/8 hours)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ibuprofen (400 mg/6 hours)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Uzara
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 60
Study: 23091132

Group type: EXPERIMENTAL
Intervention: Chlorine added to drinking water during preslaughter feed withdrawal
Number of subjects: 40

Group type: COMPARATOR
Intervention: Preslaughter feed withdrawal without chlorine
Number of subjects: 40
Study: 19428086

Group type: EXPERIMENTAL
Intervention: LIA + SCB
Number of subjects: 323

Group type: COMPARATOR
Intervention: LIA
Number of subjects: 323

Group type: COMPARATOR
Intervention: No-needle jet anesthesia
Number of subjects: 323
Study: 17486470

Group type: EXPERIMENTAL
Intervention: Estrogen plus progesterone therapy (EPT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 15847356

Group type: EXPERIMENTAL
Intervention: Itopride hydrochloride 50mg three times daily for two weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Domperidone 10mg three times daily for two weeks
Number of subjects: 56
Study: 12200521

Group type: EXPERIMENTAL
Intervention: 60 ng recombinant human TNF alpha
Number of subjects: 10

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 10
Study: 9806037

Group type: EXPERIMENTAL
Intervention: Filgrastim (300 micrograms/day up to 10 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9097710

Group type: EXPERIMENTAL
Intervention: PCNA index (percentage of PCNA positive nuclei)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: PCNA index as a new parameter in malignancy index (MI)
Number of subjects: 103
Study: 1909525

Group type: EXPERIMENTAL
Intervention: Safety condition (presence of senior and junior experimenters, junior presented as professional, personal contact with senior)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-safety condition (senior experimenter left on bogus emergency, junior presented as 'student', subjects alone)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Safety scores (pre-inhalation)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Safety scores (median-split analysis)
Number of subjects: 18
Study: 6623361

Group type: EXPERIMENTAL
Intervention: Modified amino acid solution rich in branched chains and low in aromatic amino acids and methionine (F080)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Neomycin
Number of subjects: 22
Study: 31418598

Group type: EXPERIMENTAL
Intervention: C-SSRRMT capsules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate release market tablets
Number of subjects: 0
Study: 28335893

Group type: EXPERIMENTAL
Intervention: Proximal LAD stenting
Number of subjects: 8709

Group type: COMPARATOR
Intervention: Stenting outside proximal LAD
Number of subjects: 8709
Study: 27993163

Group type: EXPERIMENTAL
Intervention: Referral to transition services (integrated practice unit with multidisciplinary care, dedicated paramedicine providers, and virtual visits)
Number of subjects: 1520

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1520
Study: 24439596

Group type: EXPERIMENTAL
Intervention: Ad lib feeding
Number of subjects: 150

Group type: COMPARATOR
Intervention: Protocol feeding
Number of subjects: 150
Study: 22422274

Group type: EXPERIMENTAL
Intervention: Oral care with toothbrushing and 0.12% chlorhexidine digluconate
Number of subjects: 436

Group type: COMPARATOR
Intervention: Oral care without toothbrushing and 0.12% chlorhexidine digluconate
Number of subjects: 436
Study: 18635695

Group type: EXPERIMENTAL
Intervention: bupropion XR (150 mg/day, increased to 300 mg/day if inadequate response)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: venlafaxine XR (75 mg/day, increased to 150 mg/day if inadequate response)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 17617284

Group type: EXPERIMENTAL
Intervention: Topical epinastine hydrochloride ophthalmic solution 0.05% twice daily for 4 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Systemic loratadine 10 mg once daily for 4 days
Number of subjects: 18
Study: 15089837

Group type: EXPERIMENTAL
Intervention: Transvaginal sacrospinous fixation (SSF)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Posterior intravaginal slingplasty (PIVS)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Sacrocolpopexy (SCP)
Number of subjects: 21
Study: 17061489

Group type: EXPERIMENTAL
Intervention: Oral metronidazole 500 mg twice daily for 7 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Oral ampicillin 2 g for 10 days
Number of subjects: 45
Study: 9836168

Group type: EXPERIMENTAL
Intervention: Subjects with chronic unilateral low back pain
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pain-free controls
Number of subjects: 30
Study: 8081076

Group type: EXPERIMENTAL
Intervention: Telenzepine 1.5 mg nocte
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telenzepine 3 mg nocte
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telenzepine 5 mg nocte
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo nocte
Number of subjects: 0
Study: 1810018

Group type: EXPERIMENTAL
Intervention: Recombinant tissue-type plasminogen activator (rt-PA)
Number of subjects: 0
Study: 6285503

Group type: EXPERIMENTAL
Intervention: Gliclazide (n = 20)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Glibenclamide (n = 15)
Number of subjects: 35
Study: 30730862

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) plus lidocaine
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo plus lidocaine
Number of subjects: 84
Study: 28871893

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Protein (PRO)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO)
Number of subjects: 12
Study: 26979261

Group type: EXPERIMENTAL
Intervention: Vapocoolant spray
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 100
Study: 23896791

Group type: EXPERIMENTAL
Intervention: 10 min Apgar score of 0-3
Number of subjects: 174

Group type: COMPARATOR
Intervention: 10 min Apgar score >3
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Each point increase in 10 min Apgar scores
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: 10 min Apgar score of 0
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Cooled infants with Apgar scores of 0-3
Number of subjects: 174
Study: 20111879

Group type: EXPERIMENTAL
Intervention: Full dental treatment
Number of subjects: 380

Group type: COMPARATOR
Intervention: No invasive treatment
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Other treatment strategies
Number of subjects: 380
Study: 19490308

Group type: EXPERIMENTAL
Intervention: Learn Young, Learn Fair program
Number of subjects: 1467
Study: 17499284

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg daily
Number of subjects: 4568

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4568
Study: 15196105

Group type: EXPERIMENTAL
Intervention: Airway pressure release ventilation (APRV)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Synchronized intermittent ventilation (SIMV)
Number of subjects: 58
Study: 12174003

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine administered into the ventrogluteal area
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine administered into the anterolateral thigh
Number of subjects: 200
Study: 9844307

Group type: EXPERIMENTAL
Intervention: Vibration perception test, electric current sensitivity test, thermal perception test
Number of subjects: 53

Group type: COMPARATOR
Intervention: Vibration perception test
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Three tests (vibration, electric current, thermal perception)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Duration of vibration exposure
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Duration of work exposure
Number of subjects: 53
Study: 8005300

Group type: EXPERIMENTAL
Intervention: RU486 (1 mg/d for 5 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3178922

Group type: EXPERIMENTAL
Intervention: Enciprazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31899117

Group type: EXPERIMENTAL
Intervention: Ultrasonography-guided corticosteroid injection (CI)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Blind corticosteroid injection (CI)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ultrasonography-guided CI
Number of subjects: 44

Group type: COMPARATOR
Intervention: Blind CI
Number of subjects: 44
Study: 31307535

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 28368486

Group type: EXPERIMENTAL
Intervention: Pulsatile GnRH therapy administered subcutaneously for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pulsatile GnRH therapy
Number of subjects: 40
Study: 26637582

Group type: EXPERIMENTAL
Intervention: Topical Vitamin A (VA)
Number of subjects: 30
Study: 24026893

Group type: EXPERIMENTAL
Intervention: Calcium carbonate 1000 mg daily + cholecalciferol 1600 IU daily
Number of subjects: 150

Group type: COMPARATOR
Intervention: Calcium carbonate 1000 mg daily
Number of subjects: 150
Study: 21566104

Group type: EXPERIMENTAL
Intervention: Rituximab (Mabthera, 375 mg/m² intravenously) with lower doses of prednisone and calcineurin inhibitors
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard therapy (current therapy alone)
Number of subjects: 54
Study: 18197434

Group type: COMPARATOR
Intervention: Intravenous ceftriaxone
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Oral moxifloxacin
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 96
Study: 16040117

Group type: COMPARATOR
Intervention: Single-step impression technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monophase impression technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-step impression technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Impression techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Position of the preparation margin
Number of subjects: 0
Study: 12548298

Group type: COMPARATOR
Intervention: Apple drink (25% fruit juice)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: TCP dispersed in water containing 1200 mg Ca
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: HCSM containing 1200 mg Ca and 65.5 mg Mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: HCSM containing 1200 mg Ca and 172 mg Mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High calcium drinks (TCP, HCSM, HCSM+Mg)
Number of subjects: 21
Study: 11460290

Group type: EXPERIMENTAL
Intervention: Water Pik Sonic Speed (W)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sonicare (S)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Manual toothbrush (Elmex Super 39, E)
Number of subjects: 36
Study: 9297766

Group type: EXPERIMENTAL
Intervention: Strontium-89 systemic radiotherapy (single injection)
Number of subjects: 0
Study: 8269451

Group type: EXPERIMENTAL
Intervention: Naproxen sodium 220 mg
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 3899046

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (0.15 mg/kg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (0.3 mg/kg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (0.6 mg/kg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 30224584

Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioral Therapy for Insomnia (CBT-I) consisting of a group session (60 min) and an individual session (30 min)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 79
Study: 26654214

Group type: EXPERIMENTAL
Intervention: 11-G vacuum-assisted biopsy (VAB)
Number of subjects: 129

Group type: COMPARATOR
Intervention: 14-G core needle biopsy (CNB)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both VAB and CNB
Number of subjects: 129
Study: 25504080

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 22898577

Group type: COMPARATOR
Intervention: Wii Fit training alone (WI group)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Physical therapy training alone (PT group)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both physical therapy and Wii Fit training (PW group)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Wii Fit training (WI group)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Physical therapy training (PT group)
Number of subjects: 17
Study: 20397024

Group type: EXPERIMENTAL
Intervention: Exercise at 8 kcal/kg/week
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Exercise at 12 kcal/kg/week
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 251
Study: 17852170

Group type: EXPERIMENTAL
Intervention: Individual cognitive behavioral therapy with attention to relapse prevention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study: 15668991

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 12414334

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra)
Number of subjects: 0
Study: 10078679

Group type: COMPARATOR
Intervention: Bupivacaine 0.125% plus 7.5 microg sufentanil
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.125% plus 7.5 microg sufentanil
Number of subjects: 130

Group type: COMPARATOR
Intervention: Bupivacaine 0.100% plus 7.5 microg sufentanil
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125% and Ropivacaine 0.125% with sufentanil
Number of subjects: 130